Health

Forget DOE data, it's time to buy ahead of The Fed!!

We suspect this won't last as the algos are struggling to catch the high stops.

2016 has been a tempestuous year for Serepta shareholders. From over $40 to just $10 and then the miracle ramp from february back to $25 before the writing on the wall ahead of last night's FDA decision and now - following yesterday's monstrous short-squeeze (36% surge), a 50% collapse to $8 - a 4 year low for yet another Biotech darling of old. This morning's collapse comes after the FDA voted that SRPT's muscular dystrophy drug was not effective...

As Bloomberg reports,

A junior doctor announced his intention to quit the NHS over unfair working conditions and pay on live TV ahead of an all-out strike. Dr Ben White stands with a multitude of disenfranchised doctors who started their working careers with the intention of helping the needy until they found out the National Health Service had turned into a for-profit organisation.

A Texas mother is speaking out against the horrific injuries her six month old daughter sustained after being given 8 vaccine doses during a routine visit to the doctors surgery.  After receiving vaccines for DTap/Hib/IPV, hepatitis B, pneumococcal Prevnar 13, and the oral Rotavirus vaccine, Cerenity suffered several major health problems which eventually led to her becoming permanently brain damaged. Prior to the vaccines Cerenity was a perfectly healthy happy baby with normal physical and cognitive development.

The Michael Pearson era at Valeant is officially over. Following a week of leaks that the troubled Canadian ex-rollup will hire Perrigo's CEO, Joseph C. Papa, moments ago the company confirmed this when the VRX board said that it has named Joseph C. Papa to become Valeant's Chairman and Chief Executive Officer (incidentally this comes on the day in which Periggo stock tumbled after the company slashed its 2016 EPS forecast from $9.50-$9.80 to $8.20-$8.50).

The full presss release: